Avance Clinical, the Australia-based global CRO partner for biotechs, has announced the launch of its dedicated Early Phase Centre of Excellence (CoE) for Biotechs, designed to deliver scientific rigor, innovative trial design, global regulatory insight, and operational excellence for smarter, more efficient early phase trials with significant cost savings for global biotechs.
The CoE solves the challenges facing early phase biotechs, including approval delays, slow site activation, and inefficient trial designs that drive up costs and compromise data quality. As a dedicated biotech accelerator, the center designs strategic and scalable programs that move seamlessly from pre-clinical through Phase I, into global expansion, and deliver expedited data insights. Services range from:
The centre’s flagship ClinicReady programme launches studies rapidly in Australia with no IND requirements accelerating access to cost effective, high-quality clinical data.
The centre leverages Avance Clinical’s scientific leads and operational experts, who guide clinical protocol development, biomarker strategy, ethics submissions, efficient trial delivery, and accelerated data access. The company’s proven Phase I unit partners and extensive site and vendor networks ensure studies launch successfully and deliver globally accepted data rapidly.
